Gastric Cancer Market

Table of Content

1. Introduction
   • Definition of Gastric Cancer Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Gastric Cancer Market, By Type
   • Adenocarcinoma
   • Lymphoma
   • Gastrointestinal Stromal Tumor
   • Carcinoid Tumor
   • Others
5. Gastric Cancer Market, By Stages
   • Stage I
   • Stage II
   • Stage III
   • Stage IV
   • Others
6. Gastric Cancer Market, By Diagnosis
   • Endoscopy
   • Biopsy
   • Imaging Tests
   • Exploratory Surgery
   • Other
7. Gastric Cancer Market, By Treatment
   • Surgery
   • Radiation Therapy
   • Chemotherapy
   • Targeted Therapy
   • Palliative Care
   • Others
8. Gastric Cancer Market, By Route of Administration
   • Oral
   • Parenteral
   • Others
9. Gastric Cancer Market, By Distribution Channel
   • Hospital Pharmacy
   • Online Pharmacy
   • Retail Pharmacy
10. Gastric Cancer Market, By End-Users
    • Hospitals
    • Homecare
    • Speciality Centres
    • Others
11. Gastric Cancer Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
12. Competitive Landscape
13. Company Profiles
    • Mylan N.V. (U.S.)
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Teva Pharmaceutical Industries Ltd.(Israel)
    • Sanofi (France)
    • Pfizer Inc. (U.S.)
    • GSK plc (U.K.)
    • Novartis AG (Switzerland)
    • Bayer AG (Germany)
    • Eli Lilly and Company (U.S.)
    • Merck & Co., Inc. (U.S.)
    • Johnson & Johnson Private Limited (U.S.)
    • Cipla Inc. (U.S.)
    • Abbott (U.S.)
    • AbbVie Inc. (U.S.)
    • Sun Pharmaceutical Industries Ltd. (India)
    • Aurobindo Pharma (India)
    • Lupin (India)
    • Hikma Pharmaceuticals PLC (U.K.)
    • Amneal Pharmaceuticals LLC. (U.S.)
    • Eisai Co., Ltd (Japan)
    • Provell Pharmaceuticals, LLC (U.S.)
    • Piramal Critical Care (India)
14. Conclusion and Future Outlook
15. Appendix
    • Research Methodology
    • About the Pharmanucleus
16. Disclaimer